Clinical Trials Directory

Trials / Completed

CompletedNCT02246777

Alcon® Ex-PRESS® Glaucoma Filtration Device in Japanese Patients

Assessment of Efficacy and Safety of the EX-PRESS® Glaucoma Filtration Device in Patients With Normal Tension Glaucoma

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
32 (actual)
Sponsor
Alcon Research · Industry
Sex
All
Age
20 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to assess the efficacy and safety of the Alcon Ex-PRESS® Glaucoma Filtration Device (Ex-PRESS) in Japanese subjects with normal tension glaucoma.

Conditions

Interventions

TypeNameDescription
DEVICEEx-PRESS® Glaucoma Filtration Device, Model P50PL

Timeline

Start date
2014-02-26
Primary completion
2016-10-24
Completion
2016-10-24
First posted
2014-09-23
Last updated
2018-07-20
Results posted
2018-07-20

Locations

1 site across 1 country: Japan

Source: ClinicalTrials.gov record NCT02246777. Inclusion in this directory is not an endorsement.

Alcon® Ex-PRESS® Glaucoma Filtration Device in Japanese Patients (NCT02246777) · Clinical Trials Directory